Article Versions Notes

Alshahrani A, Aljada A, Masood A, Mujammami M, Alfadda AA, Musambil M, Alanazi IO, Al Dubayee M, Abdel Rahman AM, Benabdelkamel H. Proteomic Profiling Identifies Distinct Regulation of Proteins in Obese Diabetic Patients Treated with Metformin. Pharmaceuticals. 2023; 16(10):1345. https://doi.org/10.3390/ph16101345

Alshahrani, Awad, Ahmad Aljada, Afshan Masood, Muhammad Mujammami, Assim A. Alfadda, Mohthash Musambil, Ibrahim O. Alanazi, Mohammed Al Dubayee, Anas M. Abdel Rahman, and Hicham Benabdelkamel. 2023. "Proteomic Profiling Identifies Distinct Regulation of Proteins in Obese Diabetic Patients Treated with Metformin" Pharmaceuticals 16, no. 10: 1345. https://doi.org/10.3390/ph16101345

Alshahrani, A., Aljada, A., Masood, A., Mujammami, M., Alfadda, A. A., Musambil, M., Alanazi, I. O., Al Dubayee, M., Abdel Rahman, A. M., & Benabdelkamel, H. (2023). Proteomic Profiling Identifies Distinct Regulation of Proteins in Obese Diabetic Patients Treated with Metformin. Pharmaceuticals, 16(10), 1345. https://doi.org/10.3390/ph16101345